# Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-immunogenicity-of-a-recombinant-tandem-repeat-dimeric-rbd-based/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shilong Yang,Yan Li,Lianpan Dai,Jianfeng Wang,Peng He,Changgui Li,Xin Fang,Chenfei Wang,Xiang Zhao,Enqi Huang,Changwei W. Wu,Zaixin Zhong,Fengze Wang,Xiaomin Duan,Siyu Tian,Lili Wu,Yan Liu,Yi Luo,Zhihai Chen,Fangjun Li,Junhua Li,Xian Yu,Hong Ren,Lihong Liu,Shufang Meng,Jinghua Yan,Zhongyu Hu,Lidong Gao,George F. Gao |
| Citations | 456 |
| DOI | 10.1016/s1473-3099(21)00127-4 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.thelancet.com/article/S1473309921001274/pdf |
| OpenAlex ID | https://openalex.org/W3137142873 |
| PMID | 33773111 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Changwei W. Wu](https://scholariq.org/researchers/changwei-w-wu/)
- [Yan Li](https://scholariq.org/researchers/yan-li-3/)
- [Hong Ren](https://scholariq.org/researchers/hong-ren/)

## Paper primary topic

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Paper topics

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [vaccines and immunoinformatics approaches](https://scholariq.org/topics/vaccines-and-immunoinformatics-approaches/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.